Genmab — Maj 2020
-
Ingen tvivl om genmab kunne få en væsentlig bedre aftale i dag hvis de måtte vælge at indgå en lignende struktur aftale.Så vil både milestones og royalities kunne løftes en hel del. Og jeg ser ikke nogen grund til de ikke også skulle afsøge markedet for nye sådan aftaler. Det er reelt "freebees" hvor der nok med en ny aftale vil kunne opnås 12-14% royalties og mere end dobbelt op på milestones
-
CANDOR making some noise at @COMyCongress #COMY20 Update here from @szusmani #mmsm https://twitter.com/auclairdan/status/1261671299765673990?s=21
-
Tak GB.
-
CONGRESS | #COMy20 | Kenneth Anderson,
@DanaFarber
, leaves us with this final message: The next steps towards a cure for multiple #myelomahttps://twitter.com/MM_Hub/status/1261684838677057536/photo/1 -
Prof. Jean-Luc Harousseau at @COMyCongress
#COMY20 on optimal choice of therapy in first #myeloma relapse. Many good triplets (including anti-CD38, elotuzumab, and next-gen PI and IMiDs-containing ones), multiple factors to take into considerationhttps://twitter.com/AuclairDan/status/1261669146145828864/photo/1 -
God morgen
-
-
Maria Mateos on dara sc https://twitter.com/onclive/status/1262081735854080003?s=21
-
FS
-
og god morgen
-
Er ikke usandsynligt. 2000 var det oprindelige kurstarget jeg satte, første gang jeg købte Genmab, for efterhånden en del år siden.
-
Det target har så flyttet sig siden, skal jeg lige skynde mig at sige.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind